Early molecular imaging response assessment based on determination of total viable tumor burden in [68Ga]Ga-PSMA-11 PET/CT independently predicts overall survival in [177Lu]Lu-PSMA-617 radioligand therapy
暂无分享,去创建一个
M. Schreckenberger | M. Bartholomä | S. Ezziddin | M. Hoffmann | F. Khreish | G. Wagenpfeil | F. Rosar | Felix Wenner | S. Dewes